Bjørn Naume

Adjunct Professor - Department of Oncology
Image of Bjørn Naume
Norwegian version of this page
Phone +47 22934732
Username
Visiting address Ullernchausseen 70 OUS Radiumhospitalet 0372 Oslo
Postal address Postboks 4950 Nydalen OUS, Rikshospitalet 0424 Oslo
Tags: USA

Publications

  • Staaf, Johan; Häkkinen, Jari; Hegardt, Cecilia; Saal, Lao H.; Kimbung, Siker & Hedenfalk, Ingrid [Show all 25 contributors for this article] (2022). RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ breast cancer. ISSN 2374-4677. 8(1). doi: 10.1038/s41523-022-00465-3.
  • Ahearn, Thomas U.; Zhang, Haoyu; Michailidou, Kyriaki; Milne, Roger L.; Bolla, Manjeet K. & Dennis, Joe [Show all 205 contributors for this article] (2022). Common variants in breast cancer risk loci predispose to distinct tumor subtypes. Breast Cancer Research. ISSN 1465-5411. 24(1), p. 1–13. doi: 10.1186/s13058-021-01484-x. Full text in Research Archive
  • Nilssen, Yngvar; Brustugun, Odd Terje; Eriksen, Morten Tandberg; Guren, Marianne; Haug, Erik Skaaheim & Naume, Bjørn [Show all 8 contributors for this article] (2022). Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015–2016. BMC Cancer. ISSN 1471-2407. 22(220). doi: 10.1186/s12885-022-09306-9. Full text in Research Archive
  • Park, Hanla A.; Neumeyer, Sonja; Michailidou, Kyriaki; Bolla, Manjeet K.; Wang, Qin & Kristensen, Vessela N. [Show all 50 contributors for this article] (2021). Mendelian randomisation study of smoking exposure in relation to breast cancer risk. British Journal of Cancer. ISSN 0007-0920. 125(8), p. 1135–1145. doi: 10.1038/s41416-021-01432-8. Full text in Research Archive
  • Johnson, Nichola; Maguire, Sarah; Morra, Anna; Kapoor, Pooja Middha; Tomczyk, Katarzyna & Kristensen, Vessela N. [Show all 50 contributors for this article] (2021). CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer. ISSN 0007-0920. 124, p. 842–854. doi: 10.1038/s41416-020-01185-w. Full text in Research Archive
  • Rye, Inga Hansine; Huse, Kanutte; Josefsson, Sarah Elisabet; Kildal, Wanja; Danielsen, Håvard Emil Greger & Schlichting, Ellen [Show all 28 contributors for this article] (2021). Breast cancer metastasis: immune profiling of lymph nodes reveals exhaustion of effector T cells and immunosuppression. Molecular Oncology. ISSN 1574-7891. 16(1), p. 88–103. doi: 10.1002/1878-0261.13047. Full text in Research Archive
  • Morra, Anna; Escala-Garcia, Maria; Beesley, Jonathan; Keeman, Renske; Canisius, Sander & Ahearn, Thomas U. [Show all 50 contributors for this article] (2021). Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research. ISSN 1465-5411. 23:86(1), p. 1–18. doi: 10.1186/s13058-021-01450-7. Full text in Research Archive
  • Hartkopf, Andreas; Brucker, Sara Y.; Taran, Florin-Andrei; Harbeck, Nadia; Au, Alexandra von & Naume, Bjørn [Show all 37 contributors for this article] (2021). Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis. European Journal of Cancer. ISSN 0959-8049. doi: 10.1016/j.ejca.2021.06.028.
  • Haugen, Mads Haugland; Lingjærde, Ole Christian; Hedenfalk, Ingrid; Garred, Øystein; Borgen, Elin & Loman, Niklas [Show all 12 contributors for this article] (2021). Protein signature predicts response to neoadjuvant treatment with chemotherapy and bevacizumab in HER2-negative breast cancers. JCO Precision Oncology (JCO PO). 5, p. 286–306. doi: 10.1200/PO.20.00086. Full text in Research Archive
  • Park, JooYong; Choi, Ji-Yeob; Choi, Jaesung; Chung, Seokang; Song, Nan & Park, Sue K [Show all 50 contributors for this article] (2021). Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies? Cancers. ISSN 2072-6694. 13:2370(10), p. 1–21. doi: 10.3390/cancers13102370. Full text in Research Archive
  • Nobre, Ana Rita; Risson, Emma; Singh, Deepak K.; Di Martino, Julie S.; Cheung, Julie F. & Wang, Jiapeng [Show all 14 contributors for this article] (2021). Bone marrow NG2+/Nestin+ mesenchymal stem cells drive DTC dormancy via TGF-β2. Nature Cancer. doi: 10.1038/s43018-021-00179-8.
  • Lien, Tonje Gulbrandsen; Ohnstad, Hege Oma; Lingjærde, Ole Christian; Vallon-Christersson, Johan; Aaserud, Marit & Sveli, My Anh Tu [Show all 12 contributors for this article] (2021). Sample preparation approach influences pam50 risk of recurrence score in early breast cancer. Cancers. ISSN 2072-6694. 13(23). doi: 10.3390/cancers13236118. Full text in Research Archive
  • Krüger, Kristi; Silwal-Pandit, Laxmi; Wik, Elisabeth; Straume, Oddbjørn; Stefansson, Ingunn Marie & Borgen, Elin [Show all 10 contributors for this article] (2021). Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer. Scientific Reports. ISSN 2045-2322. 11, p. 1–11. doi: 10.1038/s41598-021-81914-0. Full text in Research Archive
  • Hugenschmidt, Harald; Labori, Knut Jørgen; Borgen, Elin; Brunborg, Cathrine; Schirmer, Cecilie & Seeberg, Lars Thomas [Show all 8 contributors for this article] (2021). Preoperative CTC-Detection by CellSearch ® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer . Cancers. ISSN 2072-6694. 13(3). doi: 10.3390/cancers13030485. Full text in Research Archive
  • Liu, Jingjing; van der Smissen, Wendy J. C. Prager; Collee, Margriet J.; Bolla, Manjeet K.; Wang, Qin & Kristensen, Vessela N. [Show all 82 contributors for this article] (2020). Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk. Scientific Reports. ISSN 2045-2322. 10:9688(1), p. 1–14. doi: 10.1038/s41598-020-65665-y. Full text in Research Archive
  • Helland, Thomas; Naume, Bjørn; Hustad, Steinar; Bifulco, Ersilia; Kvaløy, Jan Terje & Sætersdal, Anna Barbro [Show all 18 contributors for this article] (2020). Low Z-4OHtam concentrations are associated with adverse clinical outcome among early stage premenopausal breast cancer patients treated with adjuvant tamoxifen. Molecular Oncology. ISSN 1574-7891. doi: 10.1002/1878-0261.12865. Full text in Research Archive
  • Kramer, Iris; Hooning, Maartje J.; Mavaddat, Nasim; Hauptmann, Michael; Keeman, Renske & Steyerberg, Ewout W. [Show all 54 contributors for this article] (2020). Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. American Journal of Human Genetics. ISSN 0002-9297. 107(5), p. 837–848. doi: 10.1016/j.ajhg.2020.09.001.
  • Kyte, Jon A; Røssevold, Andreas Hagen; Falk, Ragnhild Sørum & Naume, Bjørn (2020). ALICE: A randomized placebo-controlled phase II study evaluating atezolizumab combined with immunogenic chemotherapy in patients with metastatic triple-negative breast cancer. Journal of Translational Medicine. ISSN 1479-5876. 18:252, p. 1–7. doi: 10.1186/s12967-020-02424-7. Full text in Research Archive
  • Kyte, Jon A; Andresen, Nikolai Kragøe; Russnes, Hege Elisabeth Giercksky; Fretland, Signe Øien; Falk, Ragnhild Sørum & Lingjærde, Ole Christian [Show all 7 contributors for this article] (2020). ICON: A randomized phase IIb study evaluating immunogenic chemotherapy combined with ipilimumab and nivolumab in patients with metastatic hormone receptor positive breast cancer. Journal of Translational Medicine. ISSN 1479-5876. 18(1). doi: 10.1186/s12967-020-02421-w. Full text in Research Archive
  • Hugenschmidt, Harald; Labori, Knut Jørgen; Brunborg, Cathrine; Verbeke, Caroline Sophie; Seeberg, Lars Thomas & Schirmer, Cecilie [Show all 10 contributors for this article] (2020). Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information . BMC Cancer. ISSN 1471-2407. 20:1107, p. 1–13. doi: 10.1186/s12885-020-07510-z. Full text in Research Archive
  • Gythfeldt, Hedda von der Lippe; Lien, Tonje Gulbrandsen; Tekpli, Xavier; Silwal-Pandit, Laxmi; Borgen, Elin & Garred, Øystein [Show all 15 contributors for this article] (2020). Immune phenotype of tumor microenvironment predicts response to bevacizumab in neoadjuvant treatment of ER-positive breast cancer. International Journal of Cancer. ISSN 0020-7136. 147(9), p. 2515–2525. doi: 10.1002/ijc.33108. Full text in Research Archive
  • Nilssen, Yngvar; Brustugun, Odd Terje; Eriksen, Morten Tandberg; Haug, Erik Skaaheim; Naume, Bjørn & Møller, Bjørn (2020). Patient and tumour characteristics associated with inclusion in Cancer patient pathways in Norway in 2015-2016. BMC Cancer. ISSN 1471-2407. 20(1), p. 1–11. doi: 10.1186/s12885-020-06979-y. Full text in Research Archive
  • Tekpli, Xavier; Lien, Tonje Gulbrandsen; Røssevold, Andreas Hagen; Nebdal, Daniel J.H.; Borgen, Elin & Ohnstad, Hege Oma [Show all 19 contributors for this article] (2019). An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment. Nature Communications. ISSN 2041-1723. 10:5499, p. 1–14. doi: 10.1038/s41467-019-13329-5. Full text in Research Archive
  • Hartmann-Johnsen, Olaf Johan; Kåresen, Rolf; Schlichting, Ellen; Naume, Bjørn & Nygård, Jan Franz (2019). Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry. International Journal of Medical Informatics. ISSN 1386-5056. 125, p. 102–109. doi: 10.1016/j.ijmedinf.2019.03.004. Full text in Research Archive
  • Johansson, Henrik J.; Socciarelli, Fabio; Vacanti, Nathaniel M.; Haugen, Mads Haugland; Zhu, Yafeng & Siavelis, Ioannis [Show all 36 contributors for this article] (2019). Breast cancer quantitative proteome and proteogenomic landscape. Nature Communications. ISSN 2041-1723. 10:1600, p. 1–14. doi: 10.1038/s41467-019-09018-y. Full text in Research Archive
  • Nilssen, Yngvar; Brustugun, Odd Terje; Eriksen, Morten Tandberg; Gulbrandsen, Johanne; Haug, Erik Skaaheim & Naume, Bjørn [Show all 7 contributors for this article] (2019). Decreasing waiting time for treatment before and during implementation of cancer patient pathways in Norway. Cancer Epidemiology. ISSN 1877-7821. 61, p. 59–69. doi: 10.1016/j.canep.2019.05.004. Full text in Research Archive
  • Møller, Elen Kristine; Nord, Silje; Wedge, David C; Lingjærde, Ole Christian; Silwal-Pandit, Laxmi & Gythfeldt, Hedda [Show all 19 contributors for this article] (2018). Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations. Genome Medicine. ISSN 1756-994X. 10:92. doi: 10.1186/s13073-018-0601-y. Full text in Research Archive
  • Di Cosimo, Serena; Campbell, Christine; Azim, Hatem A.; Galli, Giulia; Bregni, Giacomo & Curigliano, Giuseppe [Show all 21 contributors for this article] (2018). The use of breast imaging for predicting response to neoadjuvant lapatinib, trastuzumab and their combination in HER2-positive breast cancer: Results from Neo-ALTTO. European Journal of Cancer. ISSN 0959-8049. 89, p. 42–48. doi: 10.1016/j.ejca.2017.10.036.
  • Borgen, Elin; Rypdal, Maria Christine; Sosa, Maria Soledad; Renolen, Anne; Schlichting, Ellen & Lønning, Per Eystein [Show all 9 contributors for this article] (2018). NR2F1 stratifies dormant disseminated tumor cells in breast cancer patients 11 Medical and Health Sciences 1112 Oncology and Carcinogenesis. Breast Cancer Research. ISSN 1465-5411. 20(120), p. 1–13. doi: 10.1186/s13058-018-1049-0. Full text in Research Archive
  • Jabeen, Shakila; Espinoza, Jaime; Torland, Lilly Anne; Zucknick, Manuela; Kumar, Surendra & Haakensen, Vilde Drageset [Show all 15 contributors for this article] (2018). Noninvasive profiling of serum cytokines in breast cancer patients and clinicopathological characteristics. Oncoimmunology. ISSN 2162-4011. :e1537691. doi: 10.1080/2162402X.2018.1537691. Full text in Research Archive
  • Bidard, François-Clément; Michiels, Stefan; Riethdorf, Sabine; Mueller, Volkmar; Esserman, Laura J. & Lucci, Anthony [Show all 50 contributors for this article] (2018). Circulating tumor cells in breast cancer patients treated by neoadjuvant chemotherapy: A Meta-analysis. Journal of the National Cancer Institute. ISSN 0027-8874. 110(6), p. 560–567. doi: 10.1093/jnci/djy018.
  • Jabeen, Shakila; Zucknick, Manuela; Nome, Marianne Eikhom; dannenfelser, ruth; Fleischer, Thomas & Kumar, Surendra [Show all 15 contributors for this article] (2018). Serum cytokine levels in breast cancer patients during neoadjuvant treatment with bevacizumab. Oncoimmunology. ISSN 2162-4011. 7(11), p. e1457598-1–e1457598-15. doi: 10.1080/2162402X.2018.1457598.
  • Hugenschmidt, Harald; Labori, Knut Jørgen; Brunborg, Cathrine; Verbeke, Caroline Sophie; Seeberg, Lars Thomas & Schirmer, Cecilie [Show all 10 contributors for this article] (2018). Circulating Tumor Cells are an Independent Predictor of Shorter Survival in Patients Undergoing Resection for Pancreatic and Periampullary Adenocarcinoma. Annals of Surgery. ISSN 0003-4932. 271(3), p. 549–558. doi: 10.1097/SLA.0000000000003035.
  • Helland, Thomas; Henne, Nina; Bifulco, Ersilia; Naume, Bjørn; Borgen, Elin & Kristensen, Vessela N. [Show all 15 contributors for this article] (2017). Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patients. Breast Cancer Research. ISSN 1465-5411. 19(1). doi: 10.1186/s13058-017-0916-4. Full text in Research Archive
  • Ohnstad, Hege Oma; Borgen, Elin; Falk, Ragnhild Sørum; Lien, Tonje Gulbrandsen; Aaserud, Marit & Sveli, My Anh Tu [Show all 14 contributors for this article] (2017). Prognostic value of PAM50 and risk of recurrence score in patients with early-stage breast cancer with long-term follow-up. Breast Cancer Research. ISSN 1465-5411. 19(120). doi: 10.1186/s13058-017-0911-9. Full text in Research Archive
  • Fleischer, Thomas; Tekpli, Xavier; Mathelier, Anthony; Wang, Shixiong; Nebdal, Daniel J.H. & Dhakal, Hari Prasad [Show all 16 contributors for this article] (2017). DNA methylation at enhancers identifies distinct breast cancer lineages. Nature Communications. ISSN 2041-1723. 8(1379). doi: 10.1038/s41467-017-00510-x. Full text in Research Archive
  • Gingras, Isabelle; Holmes, Eileen; De Azambuja, Evandro; Nguyen, David H.A.; Izquierdo, Miguel & Zujewski, Jo Anne [Show all 16 contributors for this article] (2017). Regional Nodal Irradiation after Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis from the ALTTO Trial. Journal of the National Cancer Institute. ISSN 0027-8874. 109(8:djw331), p. 1–7. doi: 10.1093/jnci/djw331. Full text in Research Archive
  • Nordlund, Marianne Sparby; Westgaard, Arne; Paus, Elisabeth; Øijordsbakken, Miriam; Henanger, Karoline Johansen & Naume, Bjørn [Show all 7 contributors for this article] (2017). Specific antibodies and sensitive immunoassays for the human epidermal growth factor receptors (HER2, HER3, and HER4). Tumour Biology. ISSN 1010-4283. 39(6). doi: 10.1177/1010428317707436. Full text in Research Archive
  • Bjørklund, Sunniva Maria Stordal; Panda, Anshuman; Kumar, Surendra; Seiler, Michael; Robinson, Doug & Gheeya, Jinesh [Show all 15 contributors for this article] (2017). Widespread alternative exon usage in clinically distinct subtypes of Invasive Ductal Carcinoma. Scientific Reports. ISSN 2045-2322. 7(1). doi: 10.1038/s41598-017-05537-0. Full text in Research Archive
  • dannenfelser, ruth; Nome, Marianne Eikhom; Tahiri, Andliena; Ursini-Siegel, Josie; Vollan, Hans Kristian Moen & Haakensen, Vilde Drageset [Show all 12 contributors for this article] (2017). Data-driven analysis of immune infiltrate in a large cohort of breast cancer and its association with disease progression, ER activity, and genomic complexity. OncoTarget. ISSN 1949-2553. 8(34), p. 57121–57133. doi: 10.18632/oncotarget.19078. Full text in Research Archive
  • Egeland, Eivind Valen; Pedersen, Kjetil Boye; Park, Daehoon; Synnestvedt, Marit; Sauer, Torill & Naume, Bjørn [Show all 27 contributors for this article] (2017). Prognostic significance of S100A4-expression and subcellular localization in early-stage breast cancer. Breast Cancer Research and Treatment. ISSN 0167-6806. 162(1), p. 127–137. doi: 10.1007/s10549-016-4096-1. Full text in Research Archive
  • Silwal-Pandit, Laxmi; Nord, Silje; Gythfeldt, Hedda; Møller, Elen Kristine; Fleischer, Thomas & Rødland, Einar Andreas [Show all 25 contributors for this article] (2017). The longitudinal transcriptional response to neoadjuvant chemotherapy with and without bevacizumab in breast cancer. Clinical Cancer Research. ISSN 1078-0432. 23(16), p. 4662–4670. doi: 10.1158/1078-0432.CCR-17-0160. Full text in Research Archive
  • Aure, Miriam Ragle; Vitelli, Valeria; Jernström, Sandra Johanna; Kumar, Surendra; Krohn, Marit & Due, Eldri Undlien [Show all 34 contributors for this article] (2017). Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome. Breast Cancer Research. ISSN 1465-5411. 19. doi: 10.1186/s13058-017-0812-y. Full text in Research Archive
  • Seeberg, Lars Thomas; Brunborg, Cathrine; Waage, Anne; Hugenschmidt, Harald; Renolen, Anne & Stav, Ingunn [Show all 11 contributors for this article] (2017). Survival Impact of Primary Tumor Lymph Node Status and Circulating Tumor Cells in Patients with Colorectal Liver Metastases . Annals of Surgical Oncology. ISSN 1068-9265. 24(8), p. 2113–2121. doi: 10.1245/s10434-017-5818-2.
  • Reinertsen, Kristin Valborg; Engebråten, Olav; Loge, Jon Håvard; Småstuen, Milada Cvancarova; Naume, Bjørn & Wist, Erik [Show all 10 contributors for this article] (2017). Fatigue During and After Breast Cancer Therapy—A Prospective Study. Journal of Pain and Symptom Management. ISSN 0885-3924. 53(3), p. 551–560. doi: 10.1016/j.jpainsymman.2016.09.011. Full text in Research Archive
  • Jerusalem, Guy; Mariani, Gabriella; Ciruelos, E.M.; Martin, M.; Tjan-Heijnen, V.C.G & Neven, P. [Show all 18 contributors for this article] (2016). Safety of everolimus plus exemestane in patients with hormone-receptor–positive, HER2–negative locally advanced or metastatic breast cancer progressing on prior non-steroidal aromatase inhibitors: primary results of a phase IIIb, open-label, single-arm, expanded-access multicenter trial (BALLET). Annals of Oncology. ISSN 0923-7534. 27(9), p. 1719–1725. doi: 10.1093/annonc/mdw249. Full text in Research Archive
  • Demeulemeester, Jonas; Kumar, Parveen; Møller, Elen Kristine; Nord, Silje; Wedge, David C. & Peterson, April [Show all 20 contributors for this article] (2016). Tracing the origin of disseminated tumor cells in breast cancer using single-cell sequencing. Genome Biology. ISSN 1465-6906. 17(1). doi: 10.1186/s13059-016-1109-7.
  • Fleischer, Thomas; Klajic, Jovana; Aure, Miriam Ragle; Louhimo, Riku; Pladsen, Arne Valebjørg & Ottestad, Lars [Show all 18 contributors for this article] (2016). DNA methylation signature (SAM40) identifies subgroups of the Luminal A breast cancer samples with distinct survival. OncoTarget. ISSN 1949-2553. 8(1), p. 1074–1082. doi: 10.18632/oncotarget.13718.
  • Sas-Chen, Aldema; Aure, Miriam Ragle; Leibovich, Limor; Carvalho, Silvia; Enuka, Yehoshua & Körner, Cindy [Show all 38 contributors for this article] (2016). LIMT is a novel metastasis inhibiting lncRNA suppressed by EGF and downregulated in aggressive breast cancer. EMBO Molecular Medicine. ISSN 1757-4676. 8(9), p. 1052–1064. doi: 10.15252/emmm.201606198. Full text in Research Archive
  • Easton, Douglas F; Lesueur, Fabienne; Decker, Brennan; Michailidou, Kyriaki; Li, Jun & Allen, Jamie [Show all 149 contributors for this article] (2016). No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: Implications for gene panel testing. Journal of Medical Genetics. ISSN 0022-2593. 53(5), p. 298–309. doi: 10.1136/jmedgenet-2015-103529.
  • Haakensen, Vilde Drageset; Steinfeld, Israel; Saldova, Radka; Shehni, Akram Asadi; Kifer, Ilona & Naume, Bjørn [Show all 9 contributors for this article] (2016). Serum N-glycan analysis in breast cancer patients - Relation to tumour biology and clinical outcome. Molecular Oncology. ISSN 1574-7891. 10(1), p. 59–72. doi: 10.1016/j.molonc.2015.08.002.
  • Silwal-Pandit, Laxmi; Russnes, Hege Elisabeth Giercksky; Borgen, Elin; Vang, Veronica Okkenhaug; Vollan, Hans Kristian Moen & Schlichting, Ellen [Show all 11 contributors for this article] (2015). The sub-cellular localization of WRAP53 has prognostic impact in breast cancer. PLOS ONE. ISSN 1932-6203. 10:e0139965(10). doi: 10.1371/journal.pone.0139965.
  • Brudvik, Kristoffer Watten; Seeberg, Lars Thomas; Hugenschmidt, Harald; Renolen, Anne; Schirmer, Cecilie & Brunborg, Cathrine [Show all 11 contributors for this article] (2015). Detection of Circulating Tumor Cells at Surgery and at Follow-Up Assessment to Predict Survival After Two-Stage Liver Resection of Colorectal Liver Metastases. Annals of Surgical Oncology. ISSN 1068-9265. 22(12), p. 4029–4037. doi: 10.1245/s10434-015-4482-7.
  • Bjørklund, Sunniva Maria Stordal; Kristensen, Vessela N.; Seiler, Michael; Kumar, Surendra; Grenaker, Grethe Irene & Ming, Yao [Show all 12 contributors for this article] (2015). Expression of an estrogen-regulated variant transcript of the peroxisomal branched chain fatty acid oxidase ACOX2 in breast carcinomas. BMC Cancer. ISSN 1471-2407. 15(1). doi: 10.1186/s12885-015-1510-8.
  • Rye, Inga Hansine; Lundin, Pär; Månér, Susanne; Fjelldal, Renathe; Naume, Bjørn & Wigler, Michael [Show all 10 contributors for this article] (2015). Quantitative multigene FISH on breast carcinomas identifies der(1;16)(q10;p10) as an early event in luminal A tumors. Genes, Chromosomes and Cancer. ISSN 1045-2257. 54(4), p. 235–248. doi: 10.1002/gcc.22237.
  • Sahlberg, Kristine Kleivi; Bottai, Giulia; Naume, Bjørn; Burwinkel, Barbara; Calin, George A. & Børresen-Dale, Anne-Lise [Show all 7 contributors for this article] (2015). A Serum MicroRNA Signature Predicts Tumor Relapse and Survival in Triple-Negative Breast Cancer Patients. Clinical Cancer Research. ISSN 1078-0432. 21, p. 1207–1214. doi: 10.1158/1078-0432.CCR-14-2011.
  • Seeberg, Lars Thomas; Waage, Anne; Brunborg, Cathrine; Hugenschmidt, Harald; Renolen, Anne & Stav, Ingunn [Show all 11 contributors for this article] (2015). Circulating Tumor Cells in Patients With Colorectal Liver Metastasis Predict Impaired Survival. Annals of Surgery. ISSN 0003-4932. 261(1), p. 164–171. doi: 10.1097/SLA.0000000000000580.
  • Reiche, Kristin; Kasack, Katharina; Schreiber, Stephan; Luders, Torben; Due, Eldri Undlien & Naume, Bjørn [Show all 12 contributors for this article] (2014). Long non-coding rnas differentially expressed between normal versus primary breast tumor tissues disclose converse changes to breast cancer-related protein-coding genes. PLOS ONE. ISSN 1932-6203. 9(9). doi: 10.1371/journal.pone.0106076.
  • Naume, Bjørn; Synnestvedt, Marit; Falk, Ragnhild Sørum; Wiedswang, Gro; Weyde, Kjetil & Risberg, Terje [Show all 15 contributors for this article] (2014). Clinical Outcome With Correlation to Disseminated Tumor Cell (DTC) Status After DTC-Guided Secondary Adjuvant Treatment With Docetaxel in Early Breast Cancer. Journal of Clinical Oncology. ISSN 0732-183X. 32(34), p. 3848–3857. doi: 10.1200/JCO.2014.56.9327.
  • Ignatiadis, Michail; Riethdorf, Sabine; Bidard, François-Clement; Vaucher, Isabelle; Khazour, Mustapha & Rothé, Françoise [Show all 42 contributors for this article] (2014). International study on inter-reader variability for circulating tumor cells in breast cancer. Breast Cancer Research. ISSN 1465-5411. 16(2). doi: 10.1186/bcr3647.
  • Coleman, Robert; Aksnes, Anne-Kirsti; Naume, Bjørn; Garcia, Camilo; Jerusalem, Guy & Piccart, Martine [Show all 9 contributors for this article] (2014). A phase IIa, nonrandomized study of radium-223 dichloride in advanced breast cancer patients with bone-dominant disease. Breast Cancer Research and Treatment. ISSN 0167-6806. 145(2), p. 411–418. doi: 10.1007/s10549-014-2939-1.
  • Fleischer, Thomas; Frigessi, Arnoldo; Johnson, Kevin C.; Edvardsen, Hege; Touleimat, Nizar & Klajic, Jovana [Show all 15 contributors for this article] (2014). Genome-wide DNA methylation profiles in progression to in situ and invasive carcinoma of the breast with impact on gene transcription and prognosis. Genome Biology. ISSN 1465-6906. 15. doi: 10.1186/s13059-014-0435-x. Full text in Research Archive
  • Gilje, Bjørnar; Nordgård, Oddmund; Tjensvoll, Kjersti; Borgen, Elin; Synnestvedt, Marit & Smaaland, Rune [Show all 7 contributors for this article] (2014). Comparison of molecular and immunocytochemical methods for detection of disseminated tumor cells in bone marrow from early breast cancer patients. BMC Cancer. ISSN 1471-2407. 14(1). doi: 10.1186/1471-2407-14-514.
  • Fleischer, Thomas; Edvardsen, Hege; Solvang, Hiroko Kato; Daviaud, Christian; Naume, Bjørn & Børresen-Dale, Anne-Lise [Show all 8 contributors for this article] (2014). Integrated analysis of high-resolution DNA methylation profiles, gene expression, germline genotypes and clinical end points in breast cancer patients. International Journal of Cancer. ISSN 0020-7136. 134(11), p. 2615–2625. doi: 10.1002/ijc.28606.
  • Aure, Miriam Ragle; Steinfeld, I; Baumbusch, Lars Oliver; Liestøl, Knut; Lipson, Doron & Nyberg, Sandra Johanna [Show all 12 contributors for this article] (2013). Identifying In-Trans Process Associated Genes in Breast Cancer by Integrated Analysis of Copy Number and Expression Data. PLOS ONE. ISSN 1932-6203. 8(1). doi: 10.1371/journal.pone.0053014.
  • Møller, Elen Kristine; Kumar, P; Voet, Thierry; Peterson, April; Van Loo, Peter & Mathisen, Randi Margit Ruud [Show all 15 contributors for this article] (2013). Next-generation sequencing of disseminated tumor cells. Frontiers of radiation therapy and oncology. ISSN 0071-9676. doi: 10.3389/fonc.2013.00320.
  • Mikalsen, Lars Tore G; Dhakal, Hari Prasad; Bruland, Øyvind; Naume, Bjørn; Borgen, Elin & Nesland, Jahn M [Show all 7 contributors for this article] (2013). The clinical impact of mean vessel size and solidity in breast carcinoma patients. PLOS ONE. ISSN 1932-6203. 8(10). doi: 10.1371/journal.pone.0075954.
  • Synnestvedt, Marit; Borgen, Elin; Schlichting, Ellen; Schirmer, Cecilie; Renolen, Anne & Giercksky, Karl-Erik [Show all 8 contributors for this article] (2013). Disseminated tumour cells in the bone marrow in early breast cancer: morphological categories of immunocytochemically positive cells have different impact on clinical outcome. Breast Cancer Research and Treatment. ISSN 0167-6806. 138(2), p. 485–497. doi: 10.1007/s10549-013-2439-8.
  • Synnestvedt, Marit; Borgen, Elin; Russnes, Hege Elisabeth Giercksky; Kumar, Neena Theresa; Schlichting, Ellen & Giercksky, Karl-Erik [Show all 9 contributors for this article] (2013). Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy. Acta Oncologica. ISSN 0284-186X. 52(1), p. 91–101. doi: 10.3109/0284186X.2012.713508.
  • Molloy, Timothy J.; Roepman, Paul; Naume, Bjørn & van't Veer, Laura J. (2012). A Prognostic Gene Expression Profile That Predicts Circulating Tumor Cell Presence in Breast Cancer Patients. PLOS ONE. ISSN 1932-6203. 7(2). doi: 10.1371/journal.pone.0032426.
  • Dhakal, Hari Prasad; Naume, Bjørn; Synnestvedt, Marit; Borgen, Elin; Kåresen, Rolf & Schlichting, Ellen [Show all 11 contributors for this article] (2012). Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness. Histopathology. ISSN 0309-0167. 61(3), p. 350–364. doi: 10.1111/j.1365-2559.2012.04223.x.
  • Stephens, Philip J; Tarpey, Patrick; Davies, Helen; Van Loo, Peter; Greenman, Chris D. & Wedge, David C [Show all 67 contributors for this article] (2012). The landscape of cancer genes and mutational processes in breast cancer. Nature. ISSN 0028-0836. 486(7403), p. 400–404. doi: 10.1038/nature11017.
  • Kristensen, Vessela N.; Vaske, Charles J.; Ursini-Siegel, Josie; Van Loo, Peter; Nordgard, Silje H. & Sachidanandam, Ravi [Show all 15 contributors for this article] (2012). Integrated molecular profiles of invasive breast tumors and ductal carcinoma in situ (DCIS) reveal differential vascular and interleukin signaling. Proceedings of the National Academy of Sciences of the United States of America. ISSN 0027-8424. 109(8), p. 2802–2807. doi: 10.1073/pnas.1108781108.
  • Ruud Mathiesen, Randi Margit; Fjelldal, Renathe; Liestøl, Knut; Due, Eldri Undlien; Geigl, Jochen & Riethdorf, Sabine [Show all 18 contributors for this article] (2012). High-resolution analyses of copy number changes in disseminated tumor cells of patients with breast cancer. International Journal of Cancer. ISSN 0020-7136. 131(4), p. E405–E415. doi: 10.1002/ijc.26444.
  • Dhakal, Hari Prasad; Naume, Bjørn; Synnestvedt, Marit; Borgen, Elin; Kåresen, Rolf & Schlichting, Ellen [Show all 11 contributors for this article] (2012). Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact. Histology and Histopathology. ISSN 0213-3911. 27(10), p. 1315–1325.
  • Synnestvedt, Marit; Borgen, Elin; Wist, Erik; Wiedswang, Gro; Weyde, Kjetil & Risberg, Terje [Show all 12 contributors for this article] (2012). Disseminated tumor cells as selection marker and monitoring tool for secondary adjuvant treatment in early breast cancer. Descriptive results from an intervention study. BMC Cancer. ISSN 1471-2407. 12. doi: 10.1186/1471-2407-12-616. Full text in Research Archive
  • Mathiesen, Randi Margit Ruud; Borgen, Elin; Renolen, Anne; Løkkevik, Erik; Nesland, Jahn M & Anker, Gun Birgitta [Show all 13 contributors for this article] (2012). Persistence of disseminated tumor cells after neoadjuvant treatment for locally advanced breast cancer predicts poor survival. Breast Cancer Research. ISSN 1465-5411. 14(4). doi: 10.1186/bcr3242. Full text in Research Archive
  • Engebråten, Olav; Edvardsen, Hege; Løkkevik, Erik; Naume, Bjørn; Kristensen, Vessela N. & Ottestad, Lars [Show all 7 contributors for this article] (2012). Gefitinib in Combination with Weekly Docetaxel in Patients with Metastatic Breast Cancer Caused Unexpected Toxicity: Results from a Randomized Phase II Clinical Trial. ISRN Oncology. ISSN 2090-5661. doi: 10.5402/2012/176789.
  • Molloy, Timothy J.; Bosma, Astrid J.; Baumbusch, Lars Oliver; Synnestvedt, Marit; Borgen, Elin & Russnes, Hege Elisabeth Giercksky [Show all 9 contributors for this article] (2011). The prognostic significance of tumour cell detection in the peripheral blood versus the bone marrow in 733 early-stage breast cancer patients. Breast Cancer Research. ISSN 1465-5411. 13(3). doi: 10.1186/bcr2898.
  • Janni, Wolfgang; Vogl, Florian D.; Wiedswang, Gro; Synnestvedt, Marit; Fehm, Tanja & Jückstock, Julia [Show all 15 contributors for this article] (2011). Persistence of Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients Predicts Increased Risk for Relapse-A European Pooled Analysis. Clinical Cancer Research. ISSN 1078-0432. 17(9), p. 2967–2976. doi: 10.1158/1078-0432.CCR-10-2515.
  • Kamalakaran, Sitharthan; Varadan, Vinay; Russnes, Hege Elisabeth Giercksky; Levy, Dan; Kendall, Jude & Janevski, Angel [Show all 23 contributors for this article] (2011). DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables. Molecular Oncology. ISSN 1574-7891. 5(1), p. 77–92. doi: 10.1016/j.molonc.2010.11.002.
  • Effenberger, K.E.; Borgen, Elin; Eulenburg, C.Z.; Bartkowiak, K.; Grosser, A. & Synnestvedt, Marit [Show all 11 contributors for this article] (2011). Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern. Breast Cancer Research and Treatment. ISSN 0167-6806. 125(3), p. 729–738. doi: 10.1007/s10549-010-0911-2.
  • Enerly, Espen; Steinfeld, Israel; Kleivi, Kristine; Leivonen, Suvi-Katri; Aure, Miriam Ragle & Russnes, Hege Elisabeth Giercksky [Show all 16 contributors for this article] (2011). miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors. PLOS ONE. ISSN 1932-6203. 6(2). doi: 10.1371/journal.pone.0016915.
  • Zhao, Xi; Rødland, Einar Andreas; Sørlie, Therese; Naume, Bjørn; Langerød, Anita & Frigessi, Arnoldo [Show all 8 contributors for this article] (2011). Combining Gene Signatures Improves Prediction of Breast Cancer Survival. PLOS ONE. ISSN 1932-6203. 6(3). doi: 10.1371/journal.pone.0017845.
  • Rønneberg, Jo Anders; Fleischer, Thomas; Solvang, Hiroko Kato; Nordgard, Silje H.; Edvardsen, Hege & Potapenko, Ivan Olegovich [Show all 14 contributors for this article] (2011). Methylation profiling with a panel of cancer related genes: Association with estrogen receptor, TP53 mutation status and expression subtypes in sporadic breast cancer. Molecular Oncology. ISSN 1574-7891. 5(1), p. 61–76. doi: 10.1016/j.molonc.2010.11.004.
  • Fangberget, Anne; Nilsen, Line; Hole, Knut Håkon; Holmen, Marit Muri; Engebråten, Olav & Naume, Bjørn [Show all 9 contributors for this article] (2011). Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. European Radiology. ISSN 0938-7994. 21(6), p. 1188–1199. doi: 10.1007/s00330-010-2020-3.
  • Van Belle, Vanya; Van Calster, Ben; Brouckaert, Olivier; Bempt, Isabelle Vanden; Pintens, Saskia & Harvey, Vernon [Show all 20 contributors for this article] (2010). Qualitative Assessment of the Progesterone Receptor and HER2 Improves the Nottingham Prognostic Index Up to 5 Years After Breast Cancer Diagnosis. Journal of Clinical Oncology. ISSN 0732-183X. 28(27), p. 4129–4134. doi: 10.1200/JCO.2009.26.4200.
  • Russnes, Hege Elisabeth Giercksky; Vollan, Hans Kristian Moen; Lingjærde, Ole Christian; Krasnitz, Alexander; Lundin, Pär & Naume, Bjørn [Show all 23 contributors for this article] (2010). Genomic Architecture Characterizes Tumor Progression Paths and Fate in Breast Cancer Patients. Science Translational Medicine. ISSN 1946-6234. 2(38), p. 38–47. doi: 10.1126/scitranslmed.3000611.
  • van Loo, Pete; Nordgard, Silje H.; Lingjærde, Ole Christian; Russnes, Hege Elisabeth Giercksky; Rye, Inga Hansine & Wei, Sun [Show all 13 contributors for this article] (2010). Allele-specific copy number analysis of tumors. Proceedings of the National Academy of Sciences of the United States of America. ISSN 0027-8424. 107(39), p. 16910–16915. doi: 10.1073/pnas.1009843107.
  • Fu, Yi Ping; Edvardsen, Hege; Kaushiva, Alpana; Arhancet, Juan P.; Howe, TM & Kohaar, Indu [Show all 15 contributors for this article] (2010). NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations. Molecular Cancer. ISSN 1476-4598. 9. doi: 10.1186/1476-4598-9-113.
  • Nesvold, Inger-Lise Hatlinghus; Fosså, Sophie Dorothea; Holm, Inger; Naume, Bjørn & Dahl, Alv A (2010). Arm/shoulder problems in breast cancer survivors are associated with reduced health and poorer physical quality of life. Acta Oncologica. ISSN 0284-186X. 49(3), p. 347–353. doi: 10.3109/02841860903302905.

View all works in Cristin

  • Sørbye, Sveinung Wergeland; Sundstrøm, Stein Harald; Stensvold, Andreas & Naume, Bjørn (2014). Funnene som vil endre kreftbehandlingen. [Newspaper]. Dagbladet.
  • Mathiesen, Randi R.; Borgen, Elin; Sætersdal, Anna Barbro; Fangberget, Anne; Schirmer, Cecilie & Stav, I [Show all 10 contributors for this article] (2013). Detection and monitoring of circulating endothelial cells, circulating tumor cells and disseminated tumor cells during neoadjuvant breast cancer treatment including bevacizumab.
  • Møller, Elen Kristine; Vollan, Hans Kristian Moen; Nord, Silje; von der Lippe Gythfeldt, H; Edvardsen, Hege & Silwal-Pandit, Laxmi [Show all 20 contributors for this article] (2013). A time course study of genomic instability in breast cancer patients receiving neoadjuvant chemotherapy with or without bevacizumab.
  • Engebråten, Olav; Vaske, Charles J.; Krohn, Marit; Silwal-Pandit, Laxmi; Vollan, Hans Kristian Moen & Møller, Elen Kristine [Show all 20 contributors for this article] (2013). Molecular response in breast cancer tumors treated with neoadjuvant chemotherapy with and without bevacizumab: Results from NeoAva - A randomized study.
  • Nord, Silje; Lingjærde, Ole Christian; Nebdal, Daniel; Sun, Wei; Alnæs, Grete & Van Loo, Peter [Show all 9 contributors for this article] (2012). Dissecting the genetic components of breast cancer transcriptomes.
  • Nord, S; Lingjærde, Ole Christian; Nebdal, D; Sun, W.; Alnaes, GIG & Van Loo, P [Show all 9 contributors for this article] (2012). Proffered Paper: Dissecting the Genetic Components of Breast Cancer Transcriptomes. European Journal of Cancer. ISSN 0959-8049. 48(supp. 5), p. S9–S9.
  • Fleischer, Thomas; Jovanovic, Jovana; Edvardsen, Hege; Alnaes, GIG; Naume, Bjørn & Tost, J [Show all 8 contributors for this article] (2012). DNA Methylation Profiling Identifies Luminal a Breast Tumors With Poor Survival. European Journal of Cancer. ISSN 0959-8049. 48, p. S140–S140.
  • Fleischer, T; Jovanovic, J; Edvardsen, Hege; Grenaker, Grethe Irene; Naume, Bjørn & Børresen-Dale, Anne-Lise [Show all 8 contributors for this article] (2011). Luminal A Breast Tumours Divided in Two Clusters by DNA Methylation. European Journal of Cancer. ISSN 0959-8049. 47, p. S97–S97.
  • Prokunina-Olsson, Ludmila; Fu, Yi Ping; Edvardsen, Hege; Kaushiva, Alpana; Kohaar, Indu & Porter-Gill, Patricia [Show all 10 contributors for this article] (2010). NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumours without TP53 mutations. European Journal of Cancer. ISSN 0959-8049. 8(5), p. 11–11.

View all works in Cristin

Published Dec. 18, 2011 6:50 PM - Last modified June 6, 2016 1:37 PM